U of A celebrates commercial potential of research More…
Benign prostatic hyperplasia may not sound familiar, but it affects 50 per cent of men over the age of 50. This condition is characterized by an enlarged prostate and causes uncomfortable urinary tract symptoms that affect men’s quality of life.
The condition isn’t preventable, but can be treated with IMBiotechnologies Ltd’s new medical device, EkobiTM Embolization Microspheres. Approved by Health Canada, EkobiTM treats enlarged prostates through artery embolization, a non-surgical technique that uses tiny beads to selectively block blood flow to the portion of the prostate that puts pressure on the urethra. As a result, the urinary tract symptoms improve. In addition to lowering urinary tract symptoms, EkobiTM can also treat hypervascularized tumours such as liver and kidney cancers.
With a life-changing product in tow, IMBiotechnologies leveraged Edmonton’s regional innovation network to accelerate product development. Through press releases announcing 510(k) FDA clearance and intellectual property and market assessments through Alberta Innovates’ voucher programs, EkobiTM is now for sale in Canada and the USA.
Today, IMBiotechnologies is conducting a clinical study at the University of Alberta to treat uterine fibroids, a benign tumour that affects over 60 per cent of women over the age of 45. Unlike the permanent implants currently on the market, EkobiTM microspheres are biodegradable and detectable by ultrasound, providing a unique and enhanced level of safety.
Learn more about TEC Edmonton’s Technology Management services. Connect with us.
This is a story from our 2017/18 annual report. Read more stories from the annual report here.
Through the Go Get Fit app, which gamifies physical activity, healthcare professionals provide fitness guidance to patients, track their progress, and support them in making fitness a part of their lifestyle. The app connects healthcare providers with community-based exercise specialists. This connection supports patients in their everyday life where transformation takes place. Endurance Unlimited first engaged with TEC Edmonton in late 2016, when TEC provided market strategy insight which in part, led to partner connections. In 2017, TEC Edmonton facilitated:
- Endurance Unlimited’s attendance and participation in the Accelerating Primary CarE (AICE) Conference.
- An application to the Alberta Innovates Accelerating Innovations into CarE (AICE) program – a collaboration between Healthy Heart Institute (Central Alberta Cardiovascular Sciences Department) and Endurance Unlimited.
Additionally, in March 2018, the Go Get Fit app was a finalist in Edmonton’s Smart Cities HealthHack competition.
Learn more about the TEC Health Accelerator: www.tecedmonton.com/health-accelerator